Correct option is B
Sol. CERVAVAC is India’s first indigenously developed vaccine for the prevention of cervical cancer. It was developed by the Serum Institute of India (SII) and launched in 2022. This vaccine provides protection against human papillomavirus (HPV), which is a major cause of cervical cancer.
Explanation of Each Option:
· MMR: Incorrect; a vaccine for measles, mumps, and rubella, unrelated to cervical cancer.
· CERVAVAC: Correct answer; India’s first indigenous cervical cancer vaccine.
· GARDASIL: Incorrect; a foreign HPV vaccine, not developed in India.
· CERVARIX: Incorrect; another HPV vaccine, but not India’s first indigenously developed one.